paynantheine

structure in first source

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

1.	Abdali, Nayereh: 1 article (03/2024)
2.	Abolhasani, Marzieh: 1 article (03/2024)
3.	Elahian, Fatemeh: 1 article (03/2024)
4.	Hosseini, Sayedeh Azimeh: 1 article (03/2024)
5.	Malekzadeh, Rahim: 1 article (03/2024)
6.	Mirzaei, Seyed Abbas: 1 article (03/2024)
7.	Nadipour Borujeni, Mohammad: 1 article (03/2024)
8.	Abdul Rahman, Siti Fairus: 1 article (10/2021)
9.	Domnic, Gregory: 1 article (10/2021)
10.	Jeng-Yeou Chear, Nelson: 1 article (10/2021)

1.	Alcoholism (Alcohol Abuse) 01/01/2021 - "We hypothesized that opioidergic kratom alkaloids like paynantheine and speciogynine with reduced µOR potency could provide a starting point for developing opioids with an improved therapeutic window to treat alcohol use disorder. "
2.	Neoplasms (Cancer) 06/01/2024 - "The effect of morphine and paynantheine on the ABCB1 gene and protein expression suggests these compounds can reduce resistance in cancer patients, but that speciociliatine may not be a suitable candidate because of its increased ABCB1 expression while speciociliatine decreased the expression of ABCG2 in MCF7MX cells. "
3.	Nasopharyngeal Carcinoma 10/28/2021 - "speciosa alkaloids (mitragynine, speciociliatine or paynantheine) as chemosensitizers for cisplatin in Nasopharyngeal carcinoma (NPC) cell lines. "